According to the American Society of Clinical Oncology (ASCO)/College of American Pathologists guidelines (CAP), ER and PgR assays are considered positive if at least 1% of the tumor cell nuclei in the sample are immunoreactive [6]. Here, ESR1 is linked to neoplasm.